Shearman & Sterling has muscled in on the epic $25bn (£14.6bn) sale of Guidant after being called in on Boston Scientific’s counterbid to Johnson & Johnson’s troubled offer.

Boston Scientific unveiled its bid for Guidant last Monday (5 December) after offering to acquire all the outstanding shares of the medical equipment manufacturer.